anxiety - Mary Jane's Post

Cannabis Science News

Why the Latest Cannabis Research on Anxiety Is Slightly Misleading

To rigorously assess how well cannabinoids work in a clinical setting, cannabis needs to be readily accessible in various chemical preparations for researchers to test.

Nicco Reggente
December 13, 2019

Press Releases

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Webcast to be held Monday, December 6 at 1:00 p.m. ET (12:00…

Business Wire
December 3, 2021
9 minute read

Press Releases

Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN—Applied DNA Sciences, Inc.…

Business Wire
December 3, 2021
2 minute read

Press Releases

cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA)…

Business Wire
December 3, 2021
3 minute read

Press Releases

Fortium Holdings Announces Licensing Agreement for Elysian Premium Cannabis Business

Agreement establishes Elysian as the exclusive Cannablue licensee in the United States…

Business Wire
December 3, 2021
4 minute read

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021

cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

Fortium Holdings Announces Licensing Agreement for Elysian Premium Cannabis Business

WM Technology, Inc. Files Form S-1 to Register Shares of Class A Common Stock Issued as Part of Q3 2021 Acquisitions